Chinese biopharmaceutical manufacturer listed on the Shenzhen Stock Exchange (000518), based in Binjiang Development Zone (Jiangyin, Jiangsu), combining biotechnology and traditional medicine, with products including recombinant human interleukin-2, epidermal growth factor, G-CSF and erythropoietin, and hepatitis and in vitro diagnostic reagents.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen